No Data
Merck, Bristol Myers Cancer Drugs Included in September FDA Advisory Panel Meeting
Here Is What to Know Beyond Why Merck & Co., Inc. (MRK) Is a Trending Stock
Express News | Merck & Co Inc: FDA's Odac Meeting to Discuss Pd-L1 Expression Thresholds Will Be Held on Sept. 26, 2024
Merck's Ebola Vaccine Showed 84% Effectiveness During Large Outbreak In Africa
Health Canada Approves Keytruda Drug to Treat Advanced Bladder Cancer
Express News | Health Canada Approves Keytruda® for the Treatment of Adult Patients With Unresectable Locally Advanced or Metastatic Urothelial Cancer (Muc) With No Prior Systemic Therapy for Muc, in Combination With Enfortumab Vedotin